Abstract
This study examines the effect of LRRK2 risk variants on the age at onset of Parkinson disease.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Age of Onset
-
Aged
-
Female
-
Genetic Association Studies
-
Genotype
-
Humans
-
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics*
-
Male
-
Middle Aged
-
Mutation / genetics*
-
Parkinson Disease / genetics*
-
United Kingdom / epidemiology
Substances
-
LRRK2 protein, human
-
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2